drugset / Trial / NCT00138047

Safety and Efficacy of Zinc Supplementation in HIV-1-Infected Children in South Africa

NCT00138047

RandomizedSingle-groupDouble-blindTreatment

Summary

The goal of the study is to rule out a harmful effect of zinc supplementation in HIV-1-infected children. The null hypothesis is that zinc supplementation will increase plasma HIV RNA levels.

Timeline

Start
2003-03
Primary completion
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc Sulfate Unknown 10 mg